MedTrace Logo

The Implication of Plasma ctDNA Methylation Haplotypes in Detecting Colorectal Cancer and Adenomas

NCT03737591 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1138

Last updated 2022-01-25

No results posted yet for this study

Summary

This is a multicenter, clinical study. This study is to evaluate the sensitivity of plasma ctDNA methylation haplotypes in detecting colorectal cancer, adenoma and the specificity in healthy individuals.

Conditions

Interventions

DIAGNOSTIC_TEST

Next-generation sequencing (NGS)

NGS test for colorectal tumor-specific plasma ctDNA methylation markers prior to endoscopy

Sponsors & Collaborators

  • Southern Medical University, China

    collaborator OTHER

  • Fudan University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-05-01
Primary Completion
2018-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03737591 on ClinicalTrials.gov